For research protocol design purposes, this suggests that 48 weeks may be an insufficient observation window to capture the full weight loss potential of retatrutide at the 12mg dose
While most are mild and temporary, its crucial to know which symptoms might need medical attention to ensure your treatment stays safe and effective
In the absence of a headtohead comparison, these findings may help to guide clinician decisions and enable pharmacoeconomic assessment of the most suitable incretinbased treatment for patients with T2D
ClinicalTrials.gov retatrutide trial records list registered studies, protocols, and recruitment details when available
Take your dose when you remember, unless it's close to your next scheduled dose
Share a complete list of everything you take prescriptions, over-the-counter products, vitamins, and supplements during your consultation